Fatal varicella due to the vaccine-strain varicella-zoster virus

References

• Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics 2011; 127:238 - 45; http://dx.doi.org/10.1542/peds.2010-0962; PMID: 21199857
   PubMed Web of Science ®Google Scholar
• Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics 2011; 128:214 - 20; http://dx.doi.org/10.1542/peds.2010-3385; PMID: 21788222
   PubMed Web of Science ®Google Scholar
• Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, Seward JF. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis 2008; 197:Suppl 2 S170 - 7; http://dx.doi.org/10.1086/522161; PMID: 18419393
   PubMed Web of Science ®Google Scholar
• Jean-Philippe P, Freedman A, Chang MW, Steinberg SP, Gershon AA, LaRussa PS, Borkowsky W. Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction. Pediatrics 2007; 120:e1345 - 9; http://dx.doi.org/10.1542/peds.2004-1681; PMID: 17974726
   PubMedGoogle Scholar
• Marin M, Güris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:RR-4 1 - 40; PMID: 17585291
   PubMedGoogle Scholar
• Willis ED, Sweet A, Lievano F, Nicholson O, Dana A. Reported adverse experiences in patients with unknown immunosuppressive conditions vaccinated with Varivax. In: Program and abstracts of the 47th annual meeting of the Infectious Diseases Society of America (Philadelphia, PA). Arlington, VA: Infectious Diseases Society of America, 2009:1176.
   Google Scholar
• Banovic T, Yanilla M, Simmons R, Robertson I, Schroder WA, Raffelt NC, Wilson YA, Hill GR, Hogan P, Nourse CB. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression. J Infect Dis 2011; 204:1893 - 901; http://dx.doi.org/10.1093/infdis/jir660; PMID: 22043019
   PubMed Web of Science ®Google Scholar
• Bryan CJ, Prichard MN, Daily S, Jefferson G, Hartline C, Cassady KA, Hilliard L, Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma. Pediatr Infect Dis J 2008; 27:946 - 8; http://dx.doi.org/10.1097/INF.0b013e318175d85c; PMID: 18776818
   PubMed Web of Science ®Google Scholar
• Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197:Suppl 2 S165 - 9; http://dx.doi.org/10.1086/522125; PMID: 18419392
   PubMed Web of Science ®Google Scholar
• Ghaffar F, Carrick K, Rogers BB, Margraf LR, Krisher K, Ramilo O. Disseminated infection with varicella-zoster virus vaccine strain presenting as hepatitis in a child with adenosine deaminase deficiency. Pediatr Infect Dis J 2000; 19:764 - 6; http://dx.doi.org/10.1097/00006454-200008000-00022; PMID: 10959752
   PubMed Web of Science ®Google Scholar
• Kramer JM, LaRussa P, Tsai WC, Carney P, Leber SM, Gahagan S, Steinberg S, Blackwood RA. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child. Pediatrics 2001; 108:E39; http://dx.doi.org/10.1542/peds.108.2.e39; PMID: 11483849
   PubMedGoogle Scholar
• Levin MJ, Dahl KM, Weinberg A, Giller R, Patel A, Krause PR. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J Infect Dis 2003; 188:954 - 9; http://dx.doi.org/10.1086/378502; PMID: 14513413
   PubMed Web of Science ®Google Scholar
• Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, Weinberg A, Wilson SB, Shaulov A, Fleisher G, Geha RS, et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis 2003; 188:948 - 53; http://dx.doi.org/10.1086/378503; PMID: 14513412
   PubMed Web of Science ®Google Scholar
• Schrauder A, Henke-Gendo C, Seidemann K, Sasse M, Cario G, Moericke A, Schrappe M, Heim A, Wessel A. Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet 2007; 369:1232; http://dx.doi.org/10.1016/S0140-6736(07)60567-4; PMID: 17416267
   PubMed Web of Science ®Google Scholar
• Sharrar RG, LaRussa P, Galea SA, Steinberg SP, Sweet AR, Keatley RM, Wells ME, Stephenson WP, Gershon AA. The postmarketing safety profile of varicella vaccine. Vaccine 2000; 19:916 - 23; http://dx.doi.org/10.1016/S0264-410X(00)00297-8; PMID: 11115716
   PubMed Web of Science ®Google Scholar
• Wise RP, Salive ME, Braun MM, Mootrey GT, Seward JF, Rider LG, Krause PR. Postlicensure safety surveillance for varicella vaccine. JAMA 2000; 284:1271 - 9; http://dx.doi.org/10.1001/jama.284.10.1271; PMID: 10979114
   PubMed Web of Science ®Google Scholar
• Kim W. Immunology and Allergy. In: Johns Hopkins Hospital, Arcara K, Tschudy M, eds. The Harriet Lane Handbook. Philadelphia, PA: Elsevier Mosby, 2011:354-69.
   Google Scholar
• Lev A, Simon AJ, Broides A, Levi J, Garty BZ, Rosenthal E, Amariglio N, Rechavi G, Somech R. Thymic function in MHC class II-deficient patients. J Allergy Clin Immunol 2013; 131:831 - 9; http://dx.doi.org/10.1016/j.jaci.2012.10.040; PMID: 23228244
   PubMed Web of Science ®Google Scholar
• Keusch GT. Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development. Rev Infect Dis 1991; 13:Suppl 6 S486 - 91; http://dx.doi.org/10.1093/clinids/13.Supplement_6.S486; PMID: 1907399
   PubMedGoogle Scholar
• Lopez AS, Burnett-Hartman A, Nambiar R, Ritz L, Owens P, Loparev VN, Guris D, Schmid DS. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis 2008; 197:646 - 53; http://dx.doi.org/10.1086/527419; PMID: 18260757
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Varicella-Zoster Infections. In: Pickering LK, ed. Red Book: 2012 Report of the Committee on Infectious Diseases Elk Grove Village, IL: American Academy Pediatrics, 2012:774-89.
   Google Scholar
• National Center for Immunization and Respiratory Diseases. General recommendations on immunization --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60:1 - 64; PMID: 21293327
   PubMedGoogle Scholar
• Silk HJ, Guay-Woodford L, Perez-Atayde AR, Geha RS, Broff MD. Fatal varicella in steroid-dependent asthma. J Allergy Clin Immunol 1988; 81:47 - 51; http://dx.doi.org/10.1016/0091-6749(88)90219-9; PMID: 3339190
   PubMed Web of Science ®Google Scholar
• Lydick E, Kuter BJ, Zajac BA, Guess HA, NIAID Varicella Vaccine Collaborative Study Group. Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine. Vaccine 1989; 7:549 - 53; http://dx.doi.org/10.1016/0264-410X(89)90281-8; PMID: 2558454
   PubMed Web of Science ®Google Scholar
• Gershon A, Takahashi M, Seward JF. Varicella vaccine. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines: Saunders Elsevier, 2008:915-58.
   Google Scholar
• Crassard N, Souillet AL, Morfin F, Thouvenot D, Claudy A, Bertrand Y. Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant. Acta Paediatr 2000; 89:1497 - 9; http://dx.doi.org/10.1111/j.1651-2227.2000.tb02785.x; PMID: 11195245
   PubMed Web of Science ®Google Scholar
• Pahwa S, Biron K, Lim W, Swenson P, Kaplan MH, Sadick N, Pahwa R. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 1988; 260:2879 - 82; http://dx.doi.org/10.1001/jama.1988.03410190127035; PMID: 3184352
   PubMed Web of Science ®Google Scholar
• Saint-Léger E, Caumes E, Breton G, Douard D, Saiag P, Huraux JM, Bricaire F, Agut H, Fillet AM. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33:2061 - 7; http://dx.doi.org/10.1086/324503; PMID: 11702291
   PubMed Web of Science ®Google Scholar
• Wauters O, Lebas E, Nikkels AF. Chronic mucocutaneous herpes simplex virus and varicella zoster virus infections. J Am Acad Dermatol 2012; 66:e217 - 27; http://dx.doi.org/10.1016/j.jaad.2010.07.011; PMID: 21056516
   PubMed Web of Science ®Google Scholar
• Shiraki K, Matsui S, Aiba N. Susceptibility of Oka varicella vaccine strain to antiviral drugs. Vaccine 1993; 11:1380 - 2; http://dx.doi.org/10.1016/0264-410X(93)90164-S; PMID: 8310756
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H, Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:RR-4 1 - 207, quiz CE1-4; PMID: 19357635
   PubMedGoogle Scholar
• Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, et al, Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009; 58:RR-11 1 - 166; PMID: 19730409
   PubMedGoogle Scholar
• Gershon AA. Varicella vaccine: rare serious problems--but the benefits still outweigh the risks. J Infect Dis 2003; 188:945 - 7; http://dx.doi.org/10.1086/378504; PMID: 14513411
   PubMed Web of Science ®Google Scholar